Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Magagnoli

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Med (New York, N.Y.)|May 28, 2025
Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trialFelipe Pereira, Joseph Magagnoli, Meenakshi Ambati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Nature Communications|September 24, 2020
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes developmentJayakrishna Ambati, Joseph Magagnoli, Hannah Leung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Med (New York, N.Y.)|May 28, 2025
Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trialFelipe Pereira, Joseph Magagnoli, Meenakshi Ambati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Nature Communications|September 24, 2020
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes developmentJayakrishna Ambati, Joseph Magagnoli, Hannah Leung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 7